US2017299604A1PendingUtilityA1

Srm methods in alzheimer's disease and neurological disease assays

64
Assignee: INTEGRATED DIAGNOSTICS INCPriority: Apr 5, 2012Filed: Nov 18, 2016Published: Oct 19, 2017
Est. expiryApr 5, 2032(~5.7 yrs left)· nominal 20-yr term from priority
G01N 2800/2821G01N 33/6848
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are methods for developing selected reaction monitoring mass spectrometry (LC-SRM-MS) assays.

Claims

exact text as granted — not AI-modified
1 . A multiplexed LC-SRM-MS assay for the measurement of a plurality of proteins in a single sample comprising:
 a) generating a set of optimal peptides and corresponding transitions for each pro-tein monitored;   b) optimizing the collision energy for each transition such that interference among the transitions monitored is avoided;   c) selecting a set of transitions that have the greatest peak areas are monitored for each of the proteins, and wherein the selected transitions do not interfere with the ions in the sample;   d) monitoring the detected set of transitions for each protein in the sample, thereby measuring a plurality of proteins in the sample.   
     
     
         2 - 16 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.